Israel Englander’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Israel Englander’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-261,753	Closed	-$2.65M	–	7376
2022 Q3	$2.65M	Buy	261,753 +119,360	+84%	+$1.21M	﹤0.01%	3493
2022 Q2	$1.43M	Buy	142,393 +9,093	+7%	+$91.4K	﹤0.01%	4037
2022 Q1	$1.33M	Buy	+133,300	New	+$1.33M	﹤0.01%	4259

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's ARCK Position: Q4 2022 in Review

Israel Englander sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 261,753 shares — an estimated $2.65M sold.

Israel Englander first reported a position in ARCK in Q1 2022 and held it in 3 quarters. The position peaked at $2.65M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Israel Englander reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Israel Englander sold 261,753 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $2.65M.
Israel Englander first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
Israel Englander's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $2.65M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.